[1] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案. 中华传染病杂志,2001,19(1):56. [2] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [3] De Franchis R,Hadengue A,Lau G,et al. EASL international consensus conference on hepatitis B. J Hepatol,2003,39(suppl):S3-S25. [4] Chen YC,Chu CM,Yeh CT,et al. Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long term follow-up study. Hepatol Int,2007,1(1):267-273. [5] Chu CM,Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis,2006,26(2):142-152. [6] Thampani T,Chawong P,Piratatvisuth T. Liver biopsy:Complications and risk factors. World J Gastroenterol,1999,5(4):301-304. [7] Friedman SL. Hepatic fibrosis-overview. Toxicology,2008,254(3):120-129. [8] 贾继东,尹珊珊.肝纤维化的诊断和治疗进展.临床内科杂志,2002,19(4):244-246. [9] 崔文娟,朱凤群.慢性乙型肝炎肝硬化血小板减少影响因素的研究进展. 实用肝脏病杂志,2010,13(1):78-80. [10] 张占卿,陆伟,杨丽芳,等. 天冬氨酸氨基转移酶/血小板指数预测慢性乙型肝炎患者肝组织病理状态的价值. 实用肝脏病杂志,2008,11(6): 366-369. [11] Wai CT,Cheng CL,Wee A,et al. Non-invasive models for predicting histology in patients with chronic heatitis B. Liver Int,2006,26(6):666-672. [12] Pan JJ,Yang CF,Chu CJ,et al. Prediction of liver fibrosis in patients with chronic hepatitis B by seru markers. Hepatogastroenterology,2007,54(77):1503-1506. [13] Kodama T,Takehara T,Hikita H,et al. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology,2010,138(7):2487-2498. (校对:陈从新) |